Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD—Is This the Time for Model Informed Precision Dosing?

Benjamin Mecsas‐Faxon, Konstantinos Papamichael, Adam S. Cheifetz
Alimentary Pharmacology and Therapeutics · Wiley · 2026-11-05 · DOI: 10.1111/apt.71087

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles